Turning real-world evidence into better patient outcomes
Pharmaceutical manufacturers invest significant time and resources in generating real-world evidence. The challenge is turning those insights into action at the point of care.

Clinical Decision Intelligence from Guidehouse and Atropos Health uses predictive analytics and machine learning to identify patients who may benefit from treatment. The solution delivers actionable insights within existing clinical workflows, helping care teams make informed decisions and intervene sooner.

How it works

White Duotone Icons-71
Identify patients earlier

Predictive models analyze patient populations to identify individuals who may be underdiagnosed, untreated, or at increased risk, supporting earlier, more targeted intervention.

White Duotone Icons-452
Make informed decisions

Timely, evidence-based insights are available within existing clinical workflows, helping care teams recognize care gaps, evaluate potential interventions, and make informed decisions at the point of care.

White Duotone Icons-lightbulb
Enable timely follow-up

Relevant insights help care teams identify patients who may need follow-up and connect with them sooner to support appropriate care.

Proven success

 

Detecting rare diseases earlier

  • Identified 210 patients with rare disease across 50+ care sites, achieving over 90% sensitivity.  

Optimizing BP-I treatment

  • Identified opportunities to improve treatment selection for patients with BP-I, where 47% could benefit from a therapy X despite low utilization. 

Expediting treatment for PTSD

  • Identified 97 patients eligible for PTSD treatment at a single care site within six months, with a 60% positive screen-to-diagnosis conversion rate.

Surfacing an underrecognized rare disease

  • Identified a cohort of 30,000 patients that should be screened for a rare disease and helped clients prioritize sites of care for algorithm deployment.






2026-HC-WEB-038 Life Sciences CDI Landing Page Visualization-590x410

FAQs

Who is Clinical Decision Intelligence for? accordion-circle-plus accordion-circle-plus-hover accordion-circle-minus accordion-circle-minus-hover
Clinical Decision Intelligence is designed for pharmaceutical manufacturers seeking to turn real-world evidence into actionable insights that support care teams within existing clinical workflows.

Clinical Decision Intelligence applies predictive analytics and machine learning to EHR data to identify patients who may be underdiagnosed, untreated, at increased risk, or likely to benefit from a specific intervention.

Insights are delivered within existing clinical workflows in the EHR, helping care teams recognize care gaps, evaluate potential interventions, and take timely action at the point of care.

Clinical Decision Intelligence can support earlier diagnosis, more targeted treatment decisions, faster patient follow-up, and improved alignment between real-world evidence and care delivery.

Clinical Decision Intelligence has helped biopharmaceutical companies identify patients with rare diseases, find opportunities to improve BP-I treatment selection, and expedite PTSD treatment by surfacing eligible patients within clinical workflows.

Meet with our experts to see how Guidehouse and Atropos Health can help translate real-world evidence into actionable insights for your therapeutic area, patient population, or care setting.

Meet our experts





Let us guide you

Guidehouse is a global AI-led professional services firm delivering advisory, technology, and managed services to the commercial and government sectors. With an integrated business technology approach, Guidehouse drives efficiency and resilience in the healthcare, financial services, energy, infrastructure, and national security markets.

Stay ahead of the curve with our latest insights, expertly tailored to your industry.